Por favor, use este identificador para citar o enlazar este Item:http://hdl.handle.net/20.500.12105/16780
Título
Genome Editing and Inherited Cardiac Arrhythmias.
Autor(es)
Fecha de publicación
2023
Cita
Adv Exp Med Biol . 2023:1396:115-127.
Idioma
Inglés
Tipo de documento
other
Resumen
Inherited arrhythmic disorders are a group of heterogeneous diseases predisposing to life-threatening arrhythmias and sudden cardiac death. Their diagnosis is not always simple due to incomplete penetrance and genetic heterogeneity. Furthermore, the available treatments are usually invasive and merely preventive. Genome editing and especially CRISPR/Cas9 technologies have the potential to correct the genetic arrhythmogenic substrate, thereby offering a cure for these fatal diseases. To date, genome editing has allowed reproducing cardiac arrhythmias in vitro, providing a robust platform for variant pathogenicity, mechanistic, and drug-testing studies. However, in vivo approaches still need profound research regarding safety, specificity, and efficiency of the methods.
MESH
Versión en línea
DOI
Aparece en las colecciones